This site is intended for UK Healthcare Professionals only

Nutrition & weight management

Explain the importance of healthy and balanced diets.

istock-1352225167-1

MHRA approves second oral GLP-1, orforglipron, for weight loss

The MHRA has approved orforglipron (Foundayo) for use in weight management and type 2 diabetes

10 Aug 2026

nutrition-1

Medicines and nutrients: understanding the dynamics

As pharmacy increasingly focuses on prevention, medicines optimisation and personalised care, recognising important medicine and nutrient interactions can help improve patient outcomes, explains Lisa Jamieson

05 Aug 2026

wegovy-summary

Pharmacies placing ‘large orders’ with wholesalers as Wegovy tablets launch in UK

Product launching via a phased roll-out with lower strengths available first

06 Jul 2026

superdrug-summary

‘Strong interest’: Superdrug launches £99 Wegovy pill service

Chain launches service on its Online Doctor portal following MHRA oral semaglutide approval

03 Jul 2026

novo-nordisk-summary

Wegovy pill gets MHRA approval in European first

Landmark approval for once-daily GLP-1 pill welcomed, but NPA raises black market concerns

11 Jun 2026

south-asian-family-meal-spread-1

Culturally sensitive weight management advice

How to give culturally appropriate advice on diet and physical activity to people from different ethnic backgrounds when discussing weight management.

27 May 2026

lilly-summary

Lilly claims retatrutide delivers ‘bariatric-level’ weight loss in trial

Manufacturer shares ‘powerful’ results from weight loss drug trial

26 May 2026

glp-summary

DSP launches peptides-led weight management brand with £1.3m campaign

MedPal AI announces brand launch in anticipation of Wegovy pill approval

21 May 2026

man-taking-tablet-summary

One-third taking oral Wegovy are ‘early responders’ says manufacturer

Novo Nordisk unveils Wegovy 25mg tablet findings at international obesity conference

13 May 2026

semaglutide-summary

Maximum weekly Wegovy dose to be available as a single injection

MHRA announces approval of single-injection 7.2mg Wegovy pen

15 Apr 2026

mceu-114114011775121717368

Less than half of UK adults aware that GLP-1s are prescription medicines

Online ads perceived as putting pressure on women to lose weight, ASA survey finds

02 Apr 2026

exercise-summary

‘Physically active’ patients to get discount on Boots weight loss service

Health insurer offers customers up to 25% discount on Boots Online Doctor service

12 Mar 2026

mceu-41797662111771922553196

£3,000 incentive for GPs to improve access to weight loss drugs

GPs are to be offered an incentive of £3,000 to support people with obesity as part of the new GP contract to be published later this week

24 Feb 2026

obesity-glp1-conceptual-arty-1

GLP-1s: Weight loss and beyond

Aside from their usefulness in managing type 2 diabetes and weight loss, where might GLP-1 drugs fit into the treatment landscape for a range of other health conditions? Rod Tucker reports

23 Feb 2026

evidence

What happens when GLP-1 treatment stops?

GLP-1s have been hailed as a revolutionary medical breakthrough in the fight against obesity. But what happens when the drug stops? A recent analysis provides an interesting but somewhat disturbing finding. Rod Tucker takes a closer look…

20 Feb 2026

mceu-87154628311771240914967

Boots launches private weight loss service in 17 stores

Boots has launched a pilot to provide a private weight loss treatment service in 17 stores across the UK.

16 Feb 2026

Change privacy settings